Treatment

MERCAPTOPURINE , TIOGUANINE , Tecentriq 1 200 mg concentrate for solution for infusion clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
TEMPLE - Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy
This study is testing new ways to treat cancer. It combines standard cancer drugs with newer immunotherapy to see if they work better together. Researchers are also looking for the best dose and how safe this new treatment is.
For: Oncology
Denmark